The bio decontamination market comprises of products and services used for sterilization and decontamination of medical devices, pharmaceutical manufacturing facilities and isolators to remove harmful biological agents. Bio decontamination is majorly conducted using microbial reduction through physical, chemical or biological means for surfaces used in the healthcare premises and equipment. The need for bio decontamination arises due to the increasing cases of hospital acquired infections caused by bacterias, viruses and other pathogens. Strict regulations mandating periodic sterilization and disinfection of medical tools and premises to ensure safety of patients and healthcare workers has also propelled demand in the bio decontamination market.
The Global Bio Decontamination Market is estimated to be valued at US$ 268.5 Mn in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the bio decontamination market are STERIS Corporation, Ecolab, Inc., TOMI Environmental Solutions, Inc., JCE Biotechnology, Fedegari Autoclavi SpA, Howorth Air Technology Ltd., Noxilizer, Inc., ClorDiSys Solutions, Inc., Wales Group, and Wenzhou Weike Biological Laboratory Equipment Co., Ltd. STERIS Corporation dominates the global market with wide range of bio decontamination services and technologies.
Growing awareness about hospital acquired infections and stringent regulations have led to increasing demand for periodic bio decontamination of healthcare facilities. Market players are focusing on developing innovative and automated solutions to effectively decontaminate large hospital premises within a short timeframe.
North America currently dominates the global bio decontamination market. However, Asia Pacific region is expected to offer lucrative growth opportunities owing to growing healthcare infrastructure, rising medical tourism and presence of emerging economies. Key market players are focusing on expansion in Asia Pacific region through partnerships and mergers.
Market drivers: Growing prevalence of hospital acquired infections has boosted demand for bio decontamination services across healthcare facilities. Strict regulations regarding infection control and safety of medical premises also drive the bio decontamination market.
Market restraints: High cost of bio decontamination equipment and services limits its adoption in cost sensitive regions. Lack of skilled professionals for operating advanced bio decontamination technologies also poses a challenge for market growth.
Segment Analysis
The Bio Decontamination Market can be segmented into Equipment, Services, and Consumables & Accessories. The Equipment segment dominates the market owing to the repeated need for sterilization equipment by pharmaceutical & biotechnology companies to ensure product and facility safety. Further the Equipment segment can be sub-segmented into chamber-based systems, UV radiation system, and hydrogen peroxide gas plasma systems. Chamber-based systems hold the largest share as they provide360-degree decontamination of an entire room with formaldehyde or hydrogen peroxide vapors.
Global Analysis
Regionally, North America currently holds the largest share in the Bio Decontamination Market mainly due to stringent regulatory norms mandating microbial elimination from pharmaceutical manufacturing areas. Europe and the Asia Pacific are the fastest growing markets. The demand in Asia Pacific is increasing rapidly owing to the growing pharmaceutical and biotechnology industries in countries like India and China. Additionally, emerging countries are adopting novel decontamination technologies at a higher rate thereby driving the regional market growth.
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
